The observed higher GRP78 levels in the Plovdiv cohort, which also presented with a higher burden of severe clinical indicators, strongly suggests that GRP78 may serve as a valuable biomarker for identifying patients at risk of more severe COVID-19 outcomes, including pneumonia. This evidence concerns the gene HSPA5 and susceptibility to pneumonia measurement.